Interestingly, we observed that specifically in CHD patients with LDL-C levels above the median (1.8 mmol/L), PAT and EAT NOS2 expressions were significantly increased as compared to subjects with LDL-C levels below median. This evidence concerns the gene NOS2 and coronary artery disorder.